Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Neuro-Oncology

Gliomas

University Hospitals Seidman Cancer Center’s oncologists are national leaders in the diagnosis and treatment of gliomas, tailoring treatment to each patient’s age, health conditions and individual needs. As one of the best cancer hospitals in the country by U.S. News & World Report for over 20 years, UH Seidman Cancer Center is part of the National Cancer Institute (NCI)-designated Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine – one of an elite group of 53 such comprehensive cancer hospitals in the U.S.


Your health is important. Make an appointment today.

Offering in-person, video and telephone visits. Call today
to see which option is right for you. 216-844-3951
Learn more about virtual visits

What Is a Glioma?

Glioma is a term used to describe a group of tumors that develop from glial cells – the supportive cells that surround, support and protect nerve cells (neurons). About 33 percent of all brain tumors are gliomas. Also called intra-axial brain tumors because they grow within the substance of the brain and often mix with normal brain tissue, gliomas are further broken down into two main types:

  • Glioblastoma: Also known as glioblastoma multiforme (GBM), glioblastoma is the most aggressive form of astrocytoma and the most common type of astrocytoma diagnosed in adults. It is characterized by very abnormal-looking cells, high cell proliferation (mitoses), areas of dead tissue and the formation of new blood vessels. Glioblastoma can develop from a previously existing lower grade astrocytoma (about 10% of cases) or originate directly as a grade 4 glioblastoma (90% of cases). The former scenario occurs more often in younger individuals, while the latter is most prevalent in people age 60 and older.
  • Low-Grade Gliomas: These gliomas, which are slower-growing, less aggressive tumors than glioblastoma, include:
    • Astrocytomas: These tumors develop from astrocytes, the same star-shaped supportive cells from which glioblastoma develops. Low-grade astrocytomas are slower-growing and less aggressive than glioblastoma, and as such, are easier to treat.
    • Oligodendrogliomas: Rare and slow-growing, these tumors originate in oligodendrocytes – a type of cell that produces a substance called myelin that functions as a protective, insulating sheath for axons (the very thin fibers that relay nerve impulses between neurons). Oligodendrogliomas can be either benign or malignant.
    • Low-grade mixed gliomas: Also called oligoastrocytomas, mixed gliomas have features of both astrocytomas and oligodendrogliomas.
    • Ganglioglioma: This very rare glioma can occur in the brain or spine and forms from both glial cells and nerve cells. Most gangliogliomas are benign.

What Are Glioma Symptoms?

Symptoms of glioma brain tumors are the same as those for many other types of brain tumors. The presence and severity of these symptoms is largely dependent on the size of the tumor and where in the brain the tumor is located. Common symptoms may include:

  • Headaches
  • Seizures
  • Loss of appetite
  • Nausea and vomiting
  • Vision or hearing problems
  • Balance problems, such as dizziness and trouble walking
  • Muscle or nervous system problems, including weakness and paralysis
  • Slurred speech
  • Mood, personality or behavior changes

Other health problems can cause many of these symptoms. See a health care provider if you have these symptoms. Only a health care provider can determine if their cause is a brain tumor or not.

What Causes Gliomas?

Like most primary tumors of the brain, the causes of gliomas are not well-understood. However, risk factors for developing a glioma include:

  • Age: Although they can occur in people of all ages, gliomas are more common in adults. More specifically, gliomas are most often seen in adults between 45 and 65 years of age. Certain types of gliomas, including pilocytic astrocytomas and ependymomas, occur more often in children and young adults.
  • Exposure to radiation: Individuals who have been exposed to ionizing radiation have an increased risk of glioma and meningioma. Ionizing radiation includes the radiation used in radiation therapy for the treatment of cancer.
  • Family history of glioma: Although it is rare for glioma to run in families, having a family history of glioma can double the risk of developing the condition. More research is needed to confirm the link between certain genetic variations and gliomas.
  • Having certain genetic disorders: In a small number of cases, certain genetic disorders (examples include neurofibromatosis type 1 or 2, von Hippel-Landau disease and tuberous sclerosis) can lead to the development of gliomas.

Glioma Survival Rates

Tiffany Hodges, MD visits a brain cancer patient Learn more about brain surgery treatment with Tiffany Hodges, MD.

Doctors can never be absolutely certain about the specific outcome for a patient following a brain tumor diagnosis. They can provide an estimate but may not be able to predict other factors, such as how well a patient responds to treatment. As such, prognosis is often revised at different stages in the care journey.

Survival rates for gliomas vary according to the type of glioma, tumor grade and the patient’s age. In addition, certain mutations can affect prognosis. The older a person is when they’re diagnosed and treated, the poorer the outlook.

A relative 5-year survival rate indicates what percent of people live at least five years after a tumor is found. The relative 5-year survival rates for ependymoma and oligodendroglioma are 83.9% and 74.1%, respectively. To see survival rate information on astrocytomas, please visit our astrocytoma page.

Innovations in Glioma Treatment

Utilizing some of the most advanced brain cancer treatments available and conducting groundbreaking clinical trials, UH Seidman Cancer Center’s physicians have established many innovations in treating gliomas and other brain cancers. This distinction means our patients have access to the most advanced treatments and therapies sooner than most other hospitals.

Current treatments for gliomas include the following:

Pioneering Clinical Research Creates New Opportunities in Brain Cancer Treatment

University Hospitals is an affiliate of Case Western Reserve University School of Medicine, a nationally recognized leader in clinical research. UH Seidman Cancer Center currently conducts a number of clinical trials for patients with gliomas and other types of brain tumors, offering patients access to new and innovative therapies and treatment options.

Learn More About Our Available Clinical Trials

Compassionate, Highly Trained Team of Experts

Our multidisciplinary group reviews and evaluates every case so that diagnosis and treatment decisions are based on the team’s combined knowledge, insights and experience. Together, we work through every step of cancer care, always with a cure in mind, always with a focus on obtaining the best possible outcome for the patient. Our care team includes:

  • Genetic counselors
  • Medical geneticists
  • Medical oncologists
  • Nurse navigators
  • Nurse practitioners
  • Pathologists
  • Radiation oncologists
  • Radiologists
  • Social workers
  • Surgical oncologists

At UH Seidman Cancer Center, each patient’s case is presented at weekly tumor board meetings, where our team conducts a disease-specific tumor board review to ensure that all treatment options are considered.

Reasons to Choose UH Seidman Cancer Center for Glioma Treatment

Member of the Adult Brain Tumor Consortium, a consortium of 11 elite Centers of Excellence for brain tumors.

Provides glioma patients with innovative clinical trials

1st

The first stereotactic radiosurgery suite in Ohio to offer Gamma Knife® technology for malignant and benign brain tumors

The first hospital in Ohio to offer proton therapy – an innovative, technologically advanced cancer treatment

2nd

The second provider east of the Mississippi to offer Medtronic’s Stealth Autoguide precision robotic platform for brain surgery

The first cancer center to offer GammaTile®, a form of radiation that dissolves in the patient’s brain after placement at the end of brain surgery

One of the leading centers in the country for minimally invasive (Laser Interstitial Thermotherapy) combined with immunotherapy

Frances’ Story: The Stars Align

After years of catering to the stars, Frances Noonan has an eye for the best. The Colorado woman also knows one’s luck can change in an instant, and traveling for a better experience can be well worth the trip.